MindMaze Overview
Company Headquarters: Lausanne, Switzerland
Founded: 2012
Workforce: ~200
Company Working: MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions dedicated to accelerating the brain's ability to recover, learn, and adapt. It is a medical device company that specializes in neurorehabilitation, virtual reality, brain imaging, neurotechnology, 3D technology, neural prediction, brain computer interface, and engineering. It works at the intersection of neuroscience, bio-sensing, engineering, mixed reality, and artificial intelligence. Its healthcare division is addressing some of neurology's most difficult problems, such as stroke, Alzheimer's disease, and Parkinson's disease, by developing a universal platform for brain health and recovery and novel digital therapeutic interventions. MindMaze's ground-breaking FDA-cleared and CE-marked neuro-digital therapeutics help patients recover from a wide range of critical neurological conditions.
It is Switzerland's first unicorn, with offices in Lausanne, Baltimore, London, Paris, and Mumbai.
Strategy
MindMaze's mission is to improve the lives of patients worldwide by developing novel digital therapeutic products for the treatment of serious neurological conditions. Its mission is to lead a neuro-focused digital health platform that addresses full-body motor and cognitive challenges associated with key neurological conditions. It believes that the demands of a rapidly aging global population make its proprietary, time-tested solutions more important than ever. It is well-positioned to dramatically improve care for millions of patients with funding and acquisition. Through this, it will be able to scale quickly.
